Salvatore Azzarelli, MD

Original Contribution

Two-Year Clinical Follow Up of Coronary Drug-Eluting Stent in
Patients at High Risk for Coronary Restenosis

08/01/2008

Alfredo Ruggero Galassi , MD;

Salvatore Azzarelli , MD;

Francesco Amico , MD;

Michele Giacoppo , MD;

Vincenzo Argentino , MD;

Antonio Fiscella , MD;

Drug-eluting stents (DES), compared with bare-metal stents (BMS), have shown a clear superiority in the prevention of restenosis and the need for further revascularization in randomized, controlled trials.1–5 Accordingly, the superiority of...

Drug-eluting stents (DES),...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Clinical and Angiographic Outcomes in Elderly Patients Treated with Endothelial Progenitor Cell Capture Coronary Stents: Results from a Prospective Single-Center Registry

12/21/2010

Francesco Amico , MD;

Michele Giacoppo , MD;

Vincenzo Argentino , MD;

Antonio Fiscella , MD;

Giuseppe Grosso , MD;

Alfredo Ruggero Galassi , MD;

Davide Tomasello , MD;

Barbara Campisano , MD;

Salvatore Azzarelli , MD;

NULL

12/21/2010

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Salvatore Azzarelli, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products